STOCK TITAN

Merit Medical (MMSI) CHRO makes 65-share charitable gift

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Merit Medical Systems chief human resources officer Michel J. Voigt reported a Form 4 showing a bona fide charitable gift of 65 shares of common stock on June 15, 2026, with no consideration received. After this gift, he holds 46,062 common shares directly and 2,265 additional shares through a 401(k) plan. He also retains non-qualified stock options covering 11,076 shares at an exercise price of $70.58, 4,046 shares at $65.03, and 2,420 shares at $56.25, vesting in 25% annual installments and expiring between 2028 and 2030. The filing reflects a small charitable disposition rather than a market sale.

Positive

  • None.

Negative

  • None.
Insider Voigt Michel J.
Role CHIEF HUMAN RESOURCES OFFICER
Type Security Shares Price Value
Gift Common Stock, No Par Value 65 $0.00 --
holding Non-qualified stock options (right to buy) -- -- --
holding Non-qualified stock options (right to buy) -- -- --
holding Non-qualified stock options (right to buy) -- -- --
holding Common Stock, No Par Value -- -- --
Holdings After Transaction: Common Stock, No Par Value — 46,062 shares (Direct, null); Non-qualified stock options (right to buy) — 2,420 shares (Direct, null); Common Stock, No Par Value — 2,265 shares (Indirect, By 401(k) Plan)
Footnotes (1)
  1. Represents plan holdings as of 06/15/2026. Represents a bona fide charitable gift of shares. No consideration was received for the transaction Become exercisable in equal annual installments of 25% commencing on 03/19/2022. Becomes exercisable in equal annual installments of 25% commencing 02/28/2023. Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
Charitable gift 65 shares Bona fide gift of common stock on June 15, 2026
Direct common shares after gift 46,062 shares Common Stock, No Par Value, direct ownership following transaction
401(k) plan holdings 2,265 shares Common Stock held indirectly by 401(k) Plan as of June 15, 2026
Options at $70.58 11,076 underlying shares Non-qualified stock options, exercise price $70.58, expiring February 28, 2030
Options at $65.03 4,046 underlying shares Non-qualified stock options, exercise price $65.03, expiring February 28, 2029
Options at $56.25 2,420 underlying shares Non-qualified stock options, exercise price $56.25, expiring March 19, 2028
Gift transaction price $0.00 per share No consideration received for 65-share charitable gift
Non-qualified stock options (right to buy) financial
"Non-qualified stock options (right to buy) with underlying Common Stock shares"
bona fide charitable gift financial
"Represents a bona fide charitable gift of shares. No consideration was received"
401(k) Plan financial
"Represents plan holdings as of 06/15/2026 held by 401(k) Plan"
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.
exercise price financial
"Non-qualified stock options with exercise price 70.5800, 65.0300 and 56.2500"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Common Stock, No Par Value financial
"Security title listed as Common Stock, No Par Value in the Form 4"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Voigt Michel J.

(Last)(First)(Middle)
1600 WEST MERIT PARKWAY

(Street)
SOUTH JORDAN UTAH 84095

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHIEF HUMAN RESOURCES OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, No Par Value2,265IBy 401(k) Plan(1)
Common Stock, No Par Value06/15/2026G65D$0(2)46,062D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-qualified stock options (right to buy)$56.2503/19/2022(3)03/19/2028Common Stock2,4202,420D
Non-qualified stock options (right to buy)$65.0302/28/2023(4)02/28/2029Common Stock4,0464,046D
Non-qualified stock options (right to buy)$70.5802/28/2024(5)02/28/2030Common Stock11,07611,076D
Explanation of Responses:
1. Represents plan holdings as of 06/15/2026.
2. Represents a bona fide charitable gift of shares. No consideration was received for the transaction
3. Become exercisable in equal annual installments of 25% commencing on 03/19/2022.
4. Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.
5. Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
/s/ Brian G. Lloyd, Attorney-in-Fact06/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MMSI executive Michel J. Voigt report?

Michel J. Voigt reported a bona fide charitable gift of 65 shares of Merit Medical common stock. The Form 4 states no consideration was received, indicating a non-market transfer rather than a sale, and leaving his overall ownership position largely unchanged.

How many MMSI shares does Michel J. Voigt hold after this Form 4?

After the reported gift, Michel J. Voigt holds 46,062 Merit Medical common shares directly. He also has 2,265 additional shares in a 401(k) plan, giving him a combined non-derivative interest exceeding 48,000 shares according to the Form 4 data provided.

What stock options does MMSI’s Michel J. Voigt still own?

Michel J. Voigt holds non-qualified stock options over 11,076 shares at $70.58, 4,046 shares at $65.03, and 2,420 shares at $56.25. These options vest in 25% annual installments and expire between 2028 and 2030, according to the disclosed terms.

Was the MMSI insider transaction a sale in the open market?

No, the Form 4 describes the 65-share transaction as a bona fide charitable gift with no consideration received. This indicates a transfer to charity rather than an open-market sale, so it does not represent selling pressure in the company’s stock.

How are Michel J. Voigt’s MMSI holdings split between direct and indirect ownership?

The Form 4 shows 46,062 Merit Medical shares held directly by Michel J. Voigt and 2,265 shares held indirectly through a 401(k) plan. Both positions are reported as non-derivative ownership stakes separate from his outstanding non-qualified stock options.